Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
0.700
-0.009 (-1.30%)
At close: Apr 25, 2024, 3:58 PM
0.726
+0.026 (3.71%)
After-hours: Apr 25, 2024, 4:00 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $4.81 million as of April 25, 2024. Its market cap has decreased by -91.11% in one year.
Market Cap
4.81M
Enterprise Value
4.52M
1-Year Change
-91.11%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $411.31M to $4.81M, a decrease of -98.83%. That is a compound annual growth rate of -78.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 4.90M | -2.00% |
Apr 23, 2024 | 5.00M | 6.38% |
Apr 22, 2024 | 4.70M | 2.17% |
Apr 19, 2024 | 4.60M | -2.13% |
Apr 18, 2024 | 4.70M | -6.00% |
Apr 17, 2024 | 5.00M | -3.85% |
Apr 16, 2024 | 5.20M | 1.96% |
Apr 15, 2024 | 5.10M | -12.07% |
Apr 12, 2024 | 5.80M | -4.92% |
Apr 11, 2024 | 6.10M | 1.67% |
Apr 10, 2024 | 6.00M | -4.76% |
Apr 9, 2024 | 6.30M | 5.00% |
Apr 8, 2024 | 6.00M | -1.64% |
Apr 5, 2024 | 6.10M | -1.61% |
Apr 4, 2024 | 6.20M | 1.64% |
Apr 3, 2024 | 6.10M | -1.61% |
Apr 2, 2024 | 6.20M | 3.33% |
Apr 1, 2024 | 6.00M | -13.04% |
Mar 28, 2024 | 6.90M | -1.43% |
Mar 27, 2024 | 7.00M | 2.94% |
Mar 26, 2024 | 6.80M | -1.45% |
Mar 25, 2024 | 6.90M | -9.21% |
Mar 22, 2024 | 7.60M | 1.33% |
Mar 21, 2024 | 7.50M | 1.35% |
Mar 20, 2024 | 7.40M | -1.33% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Hoth Therapeutics | 5.28M |
Regional Health Properties | 5.24M |
GT Biopharma | 5.22M |
Silo Pharma | 5.20M |
Acutus Medical | 5.11M |
Leafly Holdings | 4.95M |
NLS Pharmaceutics AG | 4.95M |
Predictive Oncology | 4.88M |